1. Home
  2. VOC vs CELU Comparison

VOC vs CELU Comparison

Compare VOC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VOC

VOC Energy Trust Units of Beneficial Interest

HOLD

Current Price

$2.87

Market Cap

50.7M

Sector

Energy

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.34

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VOC
CELU
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.7M
50.7M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
VOC
CELU
Price
$2.87
$1.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
60.5K
64.8K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
22.09%
N/A
EPS Growth
N/A
N/A
EPS
0.51
N/A
Revenue
$9,783,812.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
$5.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$1.00
52 Week High
$5.12
$4.35

Technical Indicators

Market Signals
Indicator
VOC
CELU
Relative Strength Index (RSI) 46.76 37.39
Support Level $2.82 $1.25
Resistance Level $2.95 $2.01
Average True Range (ATR) 0.08 0.14
MACD -0.01 -0.05
Stochastic Oscillator 10.95 21.54

Price Performance

Historical Comparison
VOC
CELU

About VOC VOC Energy Trust Units of Beneficial Interest

VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: